Markets:

Overview

News

Currencies

International

Treasuries

Compugen Ltd. - Ordinary Shares (NQ:CGEN)

2.550 -0.070 (-2.67%)

Streaming Delayed Price Updated: 9:38 AM EDT, Aug 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Compugen Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

December 19, 2023

From Gilead Sciences, Inc.

Via Business Wire

7 Promising Penny Stocks With the Potential to Defy Expectations ↗

December 15, 2023

While market speculation can get extremely dangerous, those who understand the risks may like these high-potential penny stocks.

Via InvestorPlace

Use Support And Resistance Levels To Avoid Chaos In Your Portfolio ↗

October 28, 2023

A support line is a price level where a stock historically stops declining. It can be a flat line all at one price, or it can be a trend line that gradually moves in one direction. Here is a closer...

Via Talk Markets

5 Analysts Have This to Say About Compugen ↗

August 07, 2023

Via Benzinga

Compugen Earnings Preview ↗

August 04, 2023

Via Benzinga

Expert Ratings for Compugen ↗

May 26, 2023

Via Benzinga

Compugen: Q1 Earnings Insights ↗

May 15, 2023

Via Benzinga

Earnings Preview: Compugen ↗

February 24, 2023

Via Benzinga

Why Shares of Compugen Rose on Thursday ↗

December 29, 2022

The clinical-stage biotech retreated a bit from one of its biggest days in a while.

Via The Motley Fool

Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN

June 05, 2023

Via AB Newswire

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

Why Compugen Shares Are Up Today ↗

February 28, 2023

The company released its fourth-quarter and full-year results after the bell Monday.

Via The Motley Fool

Why Compugen Stock Got Slammed Today ↗

February 08, 2023

Clinical-stage biotechs are particularly susceptible to shifts in analyst sentiment.

Via The Motley Fool

Why Shares of Compugen Rose 16.5% on Wednesday ↗

November 30, 2022

Market factors and a company announcement helped the stock climb.

Via The Motley Fool

Why Compugen Stock Crumbled Today ↗

November 14, 2022

Investors indicated their displeasure with the company's recent fundamentals.

Via The Motley Fool

Why Shares of Compugen Jumped 9.27% on Tuesday ↗

November 01, 2022

The stock's rise came after the company announced when third-quarter earnings will be presented.

Via The Motley Fool

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Analyst Ratings for Compugen ↗

August 23, 2022

Within the last quarter, Compugen (NASDAQ:CGEN) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023 ↗

February 08, 2023

Via Benzinga

Why Shares of Compugen Jumped 17.86% on Thursday ↗

November 17, 2022

The company is receiving a $7.5 milestone payment from AstraZeneca for the use of one of its therapies.

Via The Motley Fool

5 Top Stocks Cathie Wood Sold This Week ↗

September 02, 2022

August was not a pleasant month for Cathie Wood and ARKK as the ETF experienced outflows of $803 million, the most since last September.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗

November 18, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

Via Benzinga

Truist Securities Maintains Buy Rating for Compugen: Here's What You Need To Know ↗

August 23, 2022

Truist Securities has decided to maintain its Buy rating of Compugen (NASDAQ:CGEN) and lower its price target from $14.00 to $4.00. Shares of Compugen are trading up 2.29% over the last 24 hours, at...

Via Benzinga

Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday ↗

October 13, 2022

Gainers Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.

Via Benzinga

Cathie Wood Scoops Up Over $20M Worth Of Fate Therapeutics Shares, Dumps More Twitter Stock ↗

August 12, 2022

Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 05, 2022

Wednesday saw 127 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 18, 2022

During Thursday's trading, 62 companies set new 52-week lows.

Via Benzinga

JMP Securities Maintains Market Outperform Rating for Compugen: Here's What You Need To Know ↗

August 08, 2022

JMP Securities has decided to maintain its Market Outperform rating of Compugen (NASDAQ:CGEN) and lower its price target from $8.00 to $4.00. Shares of Compugen are trading up 1.37% over the last 24...

Via Benzinga

This Analyst Lowers Price Target On Lyft; Also Check Out Some Other Major PT Changes ↗

August 08, 2022

Wells Fargo cut the price target on Lyft, Inc. (NASDAQ: LYFT) from $49 to $42. However, Wells Fargo analyst Brian Fitzgerald maintained the stock with an Overweight. Lyft shares rose 0.6% to $20.41 in...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.